Breaking News Instant updates and real-time market news.

CTMX

CytomX Therapeutics

$21.37

-4.18 (-16.36%)

17:55
06/04/18
06/04
17:55
06/04/18
17:55

CytomX Therapeutics to hold a conference call

Conference call to discuss presentations of preliminary clinical results from PROCLAIM-072, an ongoing Phase 1/2 trial evaluating CX-072, at the 2018 Annual Meeting of the American Society of Clinical Oncology (ASCO) will be held June 4 at 6 pm.Webcast Link

  • 04

    Jun

  • 05

    Jun

CTMX CytomX Therapeutics
$21.37

-4.18 (-16.36%)

06/04/18
JEFF
06/04/18
NO CHANGE
Target $40
JEFF
Buy
CytomX early data point to some safety differentiation, says Jefferies
Jefferies analyst Biren Amin said he thinks some investors may have sought a better efficacy profile from CX-072. However, he notes that the Yervoy combo data provided at ASCO are in the dose-escalation phase and are in heavily pretreated patients, adding that safety seems improved with the CX-072 plus ipi combo. Amin has a Buy rating and $40 price target on CytomX shares, which are down $5.58, or 22%, to $19.96 in afternoon trading.
06/04/18
NOMU
06/04/18
NO CHANGE
NOMU
Buy
CytomX selloff after ASCO presentations 'unfounded,' says Nomura Instinet
After CytomX Therapeutics presented two presentations for its Probody CX-072 at ASCO, Nomura Instinet analyst Christopher Marai said the data "unequivocally demonstrated" that CX-072 is performing as expected and the selloff in the stock is "unfounded." After discussing with study investigators the real-world experience with CX-072, they noted that despite small numbers it was clear that immune-related adverse events typically associated with anti-PD-L1 agents were reduced, added Marai, who reiterates a Buy rating on CytomX shares.
06/01/18
RHCO
06/01/18
INITIATION
Target $38
RHCO
Buy
CytomX Therapeutics initiated with a Buy at SunTrust
SunTrust analyst Peter Lawson initiated CytomX Therapeutics with a Buy rating and $38 price target. In a research note to investors, Lawson said he is "encouraged" by the biopharma validation of CytomX's platform, while the company retains ownership of a major part of its pipeline, and believes ASCO and 2H data validates the CX-072 platform for safety and efficacy. Additionally, Lawson contends that 2H data for CX-2009 will validate the company's strategy of targeting "undruggable" antigens, unlocking two components of CytomX's valuation. Further, he believes three readouts in 2018 -- updated CX-027 data at ASCO, initial Phase 1/2 data from CX-2009 in the second half of the year, and follow-on Phase 1/2 data from CX-072 in the second half -- could be positive for the company.
03/08/18
JEFF
03/08/18
NO CHANGE
Target $40
JEFF
Buy
CytomX Therapeutics price target raised to $40 from $25 at Jefferies
Jefferies analyst Biren Amin raised his price target for CytomX Therapeutics to $40 following the company's Q4 report and ahead of "multiple readouts" in 2018 expected from CX-072 and CX-2009. The analyst keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

UNH

UnitedHealth

$272.24

12.44 (4.79%)

06:34
10/17/18
10/17
06:34
10/17/18
06:34
Recommendations
UnitedHealth analyst commentary  »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLIN

Bridgeline Digital

$0.70

-0.0801 (-10.27%)

06:34
10/17/18
10/17
06:34
10/17/18
06:34
Syndicate
Bridgeline Digital 10M share Secondary priced at 50c »

ThinkEquity, a division…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCLP

Hi-Crush Partners

$9.49

-0.16 (-1.66%)

, SND

Smart Sand

$3.81

-0.07 (-1.80%)

06:32
10/17/18
10/17
06:32
10/17/18
06:32
Downgrade
Hi-Crush Partners, Smart Sand, Covia , U.S. Silica rating change  »

Jefferies downgrades four…

HCLP

Hi-Crush Partners

$9.49

-0.16 (-1.66%)

SND

Smart Sand

$3.81

-0.07 (-1.80%)

CVIA

Covia

$7.58

0.18 (2.43%)

SLCA

U.S. Silica

$18.72

0.38 (2.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

AXAHY

AXA

$0.00

(0.00%)

, TSLA

Tesla

$276.46

16.88 (6.50%)

06:32
10/17/18
10/17
06:32
10/17/18
06:32
Periodicals
AXA triples insurance premiums for Tesla vehicles in Hong Kong, SCMP reports »

Axa (AXAHY) is changing a…

AXAHY

AXA

$0.00

(0.00%)

TSLA

Tesla

$276.46

16.88 (6.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Nov

  • 13

    Dec

SP

SP Plus Corp.

$33.53

0.58 (1.76%)

06:32
10/17/18
10/17
06:32
10/17/18
06:32
Hot Stocks
SP Plus Corp. to acquire Bags for $275M in cash »

SP Plus Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OAK

Oaktree Capital

$41.58

0.5 (1.22%)

, VNO

Vornado

$68.60

1.24 (1.84%)

06:30
10/17/18
10/17
06:30
10/17/18
06:30
Periodicals
Senator Warren targets Oaktree Capital, Vornado for Toys "R" Us fund, WSJ says »

Senator Elizabeth Warren…

OAK

Oaktree Capital

$41.58

0.5 (1.22%)

VNO

Vornado

$68.60

1.24 (1.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 30

    Oct

NFLX

Netflix

$346.40

13.29 (3.99%)

06:29
10/17/18
10/17
06:29
10/17/18
06:29
Downgrade
Netflix rating change  »

Netflix downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

IFNNY

Infineon

$0.00

(0.00%)

06:27
10/17/18
10/17
06:27
10/17/18
06:27
Upgrade
Infineon rating change  »

Infineon upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FUJIY

Fujifilm

$0.00

(0.00%)

, XRX

Xerox

$26.40

0.71 (2.76%)

06:26
10/17/18
10/17
06:26
10/17/18
06:26
Periodicals
NY court gives Fujifilm 'leverage' to resume Xerox merger talks, Reuters says »

A ruling by the New York…

FUJIY

Fujifilm

$0.00

(0.00%)

XRX

Xerox

$26.40

0.71 (2.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBC

Wabco

$110.00

2.27 (2.11%)

06:26
10/17/18
10/17
06:26
10/17/18
06:26
Downgrade
Wabco rating change  »

Wabco downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 06

    Nov

  • 13

    Dec

DPZ

Domino's Pizza

$259.80

-13.325 (-4.88%)

06:24
10/17/18
10/17
06:24
10/17/18
06:24
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 27

    Nov

SELB

Selecta Biosciences

06:22
10/17/18
10/17
06:22
10/17/18
06:22
Recommendations
Selecta Biosciences analyst commentary  »

Selecta Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 23

    Oct

VMC

Vulcan Materials

$100.85

1.56 (1.57%)

06:22
10/17/18
10/17
06:22
10/17/18
06:22
Downgrade
Vulcan Materials rating change  »

Vulcan Materials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

CNHI

CNH Industrial

$11.60

0.42 (3.76%)

06:22
10/17/18
10/17
06:22
10/17/18
06:22
Downgrade
CNH Industrial rating change  »

CNH Industrial downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MLM

Martin Marietta

$171.75

3.19 (1.89%)

06:21
10/17/18
10/17
06:21
10/17/18
06:21
Downgrade
Martin Marietta rating change  »

Martin Marietta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHS

Universal Health

$124.61

1.58 (1.28%)

06:19
10/17/18
10/17
06:19
10/17/18
06:19
Recommendations
Universal Health analyst commentary  »

Piper more positive on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

T

AT&T

$32.38

0.02 (0.06%)

, CHTR

Charter

$320.87

6.99 (2.23%)

06:19
10/17/18
10/17
06:19
10/17/18
06:19
Periodicals
New York AG expands probe into net neutrality comments, NY Times reports »

New York attorney general…

T

AT&T

$32.38

0.02 (0.06%)

CHTR

Charter

$320.87

6.99 (2.23%)

CMCSA

Comcast

$35.96

0.88 (2.51%)

CMCSK

Comcast

$0.00

(0.00%)

VZ

Verizon

$53.68

0.08 (0.15%)

NFLX

Netflix

$346.40

13.29 (3.99%)

GOOG

Alphabet

$1,120.11

28.11 (2.57%)

GOOGL

Alphabet Class A

$1,133.71

32.13 (2.92%)

AMZN

Amazon.com

$1,818.00

57.01 (3.24%)

FB

Facebook

$158.81

5.25 (3.42%)

TWTR

Twitter

$29.86

1.25 (4.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

  • 13

    Nov

  • 03

    Mar

CSTR

CapStar Financial

$15.18

-0.16 (-1.04%)

06:18
10/17/18
10/17
06:18
10/17/18
06:18
Upgrade
CapStar Financial rating change  »

CapStar Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

AMZN

Amazon.com

$1,818.00

57.01 (3.24%)

06:18
10/17/18
10/17
06:18
10/17/18
06:18
Recommendations
Amazon.com analyst commentary  »

Amazon Q3 EPS view raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 25

    Oct

WDAY

Workday

06:16
10/17/18
10/17
06:16
10/17/18
06:16
Upgrade
Workday rating change  »

Workday upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANET

Arista Networks

$233.63

12.62 (5.71%)

06:16
10/17/18
10/17
06:16
10/17/18
06:16
Upgrade
Arista Networks rating change  »

Arista Networks upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 24

    Oct

  • 25

    Oct

  • 01

    Nov

FB

Facebook

$158.81

5.25 (3.42%)

06:15
10/17/18
10/17
06:15
10/17/18
06:15
Periodicals
Facebook: Data collected by Portal may be used in targeted ads, Recode reports »

Facebook has admitted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

CSX

CSX

$72.15

1.29 (1.82%)

06:13
10/17/18
10/17
06:13
10/17/18
06:13
Recommendations
CSX analyst commentary  »

CSX price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOOT

Boot Barn

$28.61

1.08 (3.92%)

06:12
10/17/18
10/17
06:12
10/17/18
06:12
Recommendations
Boot Barn analyst commentary  »

Boot Barn recent pullback…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSCO

Tractor Supply

$88.90

2.32 (2.68%)

06:09
10/17/18
10/17
06:09
10/17/18
06:09
Recommendations
Tractor Supply analyst commentary  »

Tractor Supply price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.